Tricida

Tricida

Pharmaceuticals, 7000 Shoreline Ct, South San Francisco, California, 94080, United States, 51-200 Employees

tricida.com

  • twitter
  • LinkedIn

Who is TRICIDA

Tricida, Inc., is a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (also known as TRC101), a non-absorbed, orally-administered po...

Read More

map
  • 7000 Shoreline Ct, South San Francisco, California, 94080, United States Headquarters: 7000 Shoreline Ct, South San Francisco, California, 94080, United States
  • 2013 Date Founded: 2013
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $50 Million to $100 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from TRICIDA

Tricida Org Chart and Mapping

Employees

Jacques Mowrer

Sr. Director Quality Control

Georgina Johnston

Executive Administrative Assistant

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Tricida

Answer: Tricida's headquarters are located at 7000 Shoreline Ct, South San Francisco, California, 94080, United States

Answer: Tricida's official website is https://tricida.com

Answer: Tricida's revenue is $50 Million to $100 Million

Answer: Tricida's SIC: 2834

Answer: Tricida's NAICS: 325412

Answer: Tricida has 51-200 employees

Answer: Tricida is in Pharmaceuticals

Answer: Tricida contact info: Phone number: Website: https://tricida.com

Answer: Tricida, Inc., is a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (also known as TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD). Metabolic acidosis is a chronic condition commonly caused by CKD that is believed to accelerate the progression of CKD, increase the risk of muscle wasting and cause the loss of bone density. Tricida was founded in August 2013 by a seasoned management team that has extensive experience in the development and commercialization of therapeutics, with substantial expertise in developing polymers for the treatment of kidney-related diseases.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access